In my role at Antidote, I talk to advocacy groups and patient organizations every day, so I have a good sense of patient involvement in the drug development process. But, while I speak to organizations about how they’d like to help accelerate research and provide patients with access to clinical trials, I don’t often hear from patients themselves about how they view their role in the larger ...
Continue reading